Advertisement
U.S. markets closed

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3380+0.0235 (+7.47%)
At close: 03:59PM EST
0.3110 -0.03 (-7.99%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close0.3145
Open0.3200
Bid0.3160 x 1000
Ask0.3300 x 1400
Day's Range0.3160 - 0.3380
52 Week Range0.2400 - 1.1770
Volume34,494
Avg. Volume313,006
Market Cap3.959M
Beta (5Y Monthly)1.37
PE Ratio (TTM)N/A
EPS (TTM)-1.1700
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VRPX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Virpax Pharmaceuticals, Inc.
    Analyst Report: Zimmer Biomet Holdings, Inc.Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more